Phase 1 Ectasia Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary hemorrhagic telangiectasia
Alnylam Pharmaceuticals120 enrolled16 locationsNCT06659640
Recruiting
Phase 1
A single ascending dose study of TX002100 in healthy participants
Hereditary hemorrhagic telangiectasia
Tectonic Operating Company. Inc.48 enrolled1 locationACTRN12626000242325
Recruiting
Phase 1
A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia
Hereditary Hemorrhagic Telangiectasia (HHT)
Terremoto Biosciences Inc.90 enrolled1 locationNCT07255846
Recruiting
Phase 1
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Bacterial KeratitisEctasia of CorneaKeratoconus, Unstable
Pacific Clear Vision Institute300 enrolled1 locationNCT03918408